Daiichi Sankyo Europe GmbH

Daiichi Sankyo Europe GmbH is a pharmaceutical company with a mission to provide innovative therapeutic solutions to meet diverse medical needs globally. With a strong emphasis on customer centricity in Europe, the company aims to excel in the field of Oncology while also catering to the requirements of healthcare professionals in the cardiovascular arena. Established in 1899, Daiichi Sankyo operates in 13 countries within Europe. The company emphasizes the need for dedicated and passionate individuals to drive its success. Daiichi Sankyo encourages its teams to challenge conventional thinking and share their local recipes for success, fostering a culture of collaboration and innovation. The company prides itself on the significant impact each employee can make due to its relatively smaller size compared to other pharmaceutical entities. Daiichi Sankyo values proactive, results-driven individuals who are willing to go the extra mile to achieve their objectives. For investors looking into pharma startups in Europe, Daiichi Sankyo presents itself as an organization focused on leveraging science and technology to deliver impactful healthcare solutions to patients worldwide. For more detailed information, visit Daiichi Sankyo Europe's website: https://www.daiichi-sankyo.eu/imprint/